Filing Flows › Invo Fertility (IVF) › Q2 2026 › vs Q2 2025
Invo Fertility (IVF) Q2 2026 vs Q2 2025 (year over year)
Invo Fertility's revenue rose $312K (+17%) from $1.9M in Q2 2025 to $2.2M in Q2 2026. The biggest changes: Clinic Revenue +$336K (+18%); Product −$24K (-76%).
Invo Fertility, Q2 2026: revenue $2.2M (+17% year over year), operating margin -59.3%, net earnings $889K, operating cash flow −$1.1M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Clinic Revenue | $2.2M | $1.8M | $336K | +18% |
| Product | $8K | $32K | −$24K | -76% |
| Revenue | $2.2M | $1.9M | $312K | +17% |
| Other income, net | $2.2M | $1.4M | $788K | +54% |
| Costs & expenses | $4.4M | $8.5M | −$4.0M | -48% |
| Operating costs | $3.5M | $4.9M | −$1.4M | -29% |
| Income tax | $56K | $3.6M | −$3.5M | -98% |
| Net earnings | $889K | −$5.1M | $6.0M | — |
| Cost of revenue | $60K | $3K | $57K | 20× |
| SG&A | $1.9M | $2.2M | −$286K | -13% |
| Other operating costs | $1.5M | $2.7M | −$1.2M | -44% |
| Operating cash sources | $2.1M | −$3.3M | $5.4M | — |
| Depreciation & amortization | $146K | $170K | −$24K | -14% |
| Cash used in operations | $1.1M | $1.7M | −$616K | -36% |
| Working capital & other | $2.1M | −$3.3M | $5.4M | — |
Questions
How much did Invo Fertility's revenue grow year over year in Q2 2026?
Invo Fertility's revenue rose $312K (+17%) from $1.9M in Q2 2025 to $2.2M in Q2 2026.
What drove Invo Fertility's revenue change in Q2 2026?
Clinic Revenue +$336K (+18%); Product −$24K (-76%).